Case report. A rare case of giant basal cell carcinoma and malignant melanoma by Izzo, L. et al.
CASE	  REPORT	  :	  A	  RARE	  CASE	  OF	  GIANT	  BASAL	  CELL	  CARCINOMA	  AND	  
MALIGNANT	  MELANOMA	  
Izzo	  L.	  *,	  Izzo	  S.*	  ,	  Pugliese	  F.*,	  	  Izzo	  P.*	  
	  
	  
*Università	  degli	  Studi	  di	  Roma	  “La	  Sapienza”	  	  	  




Dipartimento	  di	  Chirurgia	  “P.	  Valdoni”	  
Università	  degli	  Studi	  di	  Roma	  “La	  Sapienza”	  	  
luciano.izzo@uniroma1.it	  
Via	  G.Tomasi	  di	  Lampedusa	  9,00144,	  Rome,	  Italy	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  Key	  words:	  giant	  basal	  cell	  carcinoma,	  malignant	  melanoma,	  	  surgical	  treatment	  
	  
Introduction	  
The	  presence	  of	  two	  several	  skin	  lesions	  in	  the	  same	  patient	  is	  a	  rare	  occurrence	  in	  dermatological	  
findings.	   	   The	   associations	   of	   malignant	   melanoma	   (MM)	   and	   giant	   basal	   cell	   carcinoma	   (BCC)	  
within	   the	   same	   patient	   	   have	   only	   been	   described	   in	   few	   cases	   in	   the	   literature.1,6	   Is	   there	   a	  
common	  genetic	  origin?	  However,	  until	  now	  the	  pathogenesis	  of	  collision	  tumors	  existing	  of	  MM	  
and	  BCC	  remains	  unclear.	  We,	  therefore,	  report	  a	  case	  of	  association	  of	  MM	  and	  BCC	  in	  the	  same	  
patient.	  
CASE	  REPORT	  
A	  65	  years-­‐old	  man	  presented	  to	  our	  department	  with	  a	  2-­‐years	  history	  of	  an	  ulcer	  on	  his	  chest	  
and	  anterior	  neck.	  It	  started	  as	  a	  small	  ulcer	  and	  it	  progressively	  increased.	  Physical	  examination	  
revealed	  a	  lesion	  of	  24	  x	  13	  x	  17	  cm	  with	  no	  bone	  exposure.	  Its	  borders	  were	  sharply	  demarcated	  
and	  raised	  (picture	  1).	  
	  
	  
	  Picture	  1:	  Giant	  basal	  cell	  carcinoma	  after	  surgical	  treatment;	  
	  
Several	   biopsies	   of	   the	   lesion	   revealed	   a	   moderately	   differentiated	   basal	   cell	   carcinoma	   of	  
infiltrative	   type.	  On	   physical	   examination	   a	   second	   lesion	  was	   noted	   on	   right	   shoulder-­‐blade.	   It	  
was	   a	   firm	   brownish	   swelling	   measuring	   3	   x	   1	   cm,	   with	   no	   bleeding	   or	   ulceration.	   The	   biopsy	  
showed	   features	   of	  malignant	  melanoma.	   Laboratory	   test	   results	   including	   complete	   blood	   cell	  
count,	   urine	   analysis,	   liver	   function	   test,	   chest	   x-­‐ray,	   electrocardiogram	   and	   CT,	   were	   within	  
normal	   limits	   or	   negative.	   The	   patient	  was	   submitted	   to	   surgical	   treatment.	   The	   giant	   lesion	   of	  	  







	  Picture	  2:	  the	  lesion	  after	  surgical	  treatment;	  
 
 
	  The	  histopathology	  examination	  confirmed	  the	  diagnosis	  of	  BCC.	  The	  second	  lesion	  was	  removed	  
too,	  and	  the	  examination	  confirmed	  the	  diagnosis	  of	  MM	  (thickness	  of	  0,35	  mm,	  Clark’s	  level	  III	  ).	  
The	   patient’s	   recovery	   was	   uneventful	   and	   the	   graft	   took	   successfully.	   He	   was	   referred	   to	   the	  
oncologist	  for	  further	  treatment.	  	  
	  
Discussion:	  
Giant	  basal	  cell	  carcinoma	  is	  an	  aggressive	  variety	  of	  basal	  cell	  carcinoma	  with	  diameter	  >	  5	  cm	  (T3	  
BCC).	  It	  is	  characterized	  by	  deep	  tissue	  invasion,	  rapid	  growth,	  high	  risk	  of	  metastasis	  and	  a	  poor	  
prognosis.	  GBCC	  represent	  0,4-­‐	  1	  %	  of	  all	  BCC.7	  The	  pathogenesis	  of	  GBCC	  is	  sometimes	  linked	  to	  a	  
spontaneous	  mutation	   in	   the	   PTCH	   gene,	  mapped	   to	   the	   q22.33	   locus	   of	   chromosome	   9.8	   Risk	  
factors	   for	   the	   development	   of	   GBCC	   include	   delayed	   presentation,	   patient	   neglect,	   recurrence	  
after	   previous	   treatment,	   aggressive	   histological	   subtypes	   (morpheaform,	   micronodular,	   and	  
metatypical)	  or	  a	  history	  of	  radiation	  exposure.	  The	  most	  common	  lesions	  are	  sited	  on	  the	  back,	  
face	  or	  upper	  extremity.	  Anterior	  thoracic	  lesions	  are	  very	  rare.	  In	  our	  case,	  the	  GBCC	  is	  associated	  
with	  melanoma.9,10	   Two	   skin	   tumors	   can	   coexist	   simultaneously	   in	   the	   same	  patient,	   but	   it	   is	   a	  
much	  more	  unusual	   event.	  According	   to	   the	   literature	   review	  performed,	   there	   are	   28	   cases	  of	  
collision	  tumors	  involving	  melanoma	  and	  BCC,	  but	  there	  are	  not	  described	  cases	  of	  association	  of	  
GBCC	  with	  melanoma.11,14	  Our	  question	  is:	  it	  is	  possible	  a	  common	  pathogenesis?	  It	  is	  known	  that	  
severe	   intermittent	   exposure	   to	   sunlight	   is	   a	   common	   risk	   factor	   for	   the	   development	   of	  
melanoma	  and	  BCC.	  Some	  authors	  believe	  that	  the	  presence	  of	  a	  tumor	  may	  induce	  epithelial	  or	  
stromal	   alterations,	   responsible	   for	   the	   development	   of	   a	   second	   tumor,	   in	   the	   collision	   of	  
malignant	   neoplasm	   of	   the	   skin.9,12	   Other	   authors	   believe	   that	   the	   two	   tumors	   developed	  
independent	  of	  each	  other.13,14	  The	  studies	  published	  in	  literature	  so	  far	  not	  the	  response	  to	  our	  
question	  and	  the	  pathogenesis	  of	  the	  association	  of	  this	  two	  neoplasm	  remains	  unclear.	  Currently	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